Can electrical pulses to the abdomen boost weight loss?

NCT ID NCT07778550

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 21, 2026 · Last updated Aug 21, 2026

Summary

This trial tests whether adding electrical muscle stimulation (EMS) to a calorie-restricted diet helps overweight and obese women lose weight and control appetite as effectively as adding daily walking. Seventy-five women aged 19-45 with a BMI of 25 or higher will be randomly assigned to one of three groups: diet alone, diet plus walking, or diet plus EMS sessions. Over six weeks, researchers will measure changes in body weight, body fat, and appetite-related feelings like hunger and fullness to see if EMS offers an alternative to exercise.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Individualized energy-restricted diet, moderate-intensity walking, and electrical muscle stimulation (EMS)
What this could lead to
If successful, this could show that adding EMS to a diet offers a practical alternative to exercise for weight loss and appetite control in women who struggle with physical activity.
What could go wrong
This is a small, short-term study (75 women, 6 weeks) without long-term follow-up, so any benefits may not persist or apply broadly. EMS may cause discomfort or skin irritation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

75 people

The number who actually took part.

Started

Jan 2026

Finished

May 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 to 45 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Female participants aged 19-45 years * Body mass index (BMI) ≥25.0 kg/m² * No more than a 5% change in body weight during the previous 3 months * Premenopausal * Not participating in a regular exercise program * Applying to the center for weight management * Willing to participate and providing written informed consent Exclusion Criteria: * History of thrombosis or active thrombotic risk * Diagnosed hypertension * Pregnancy or lactation * Epilepsy * History of abdominal, gastric, or inguinal hernia * Cardiac pacemaker or other implanted electronic device * Metallic prostheses or large implants * Bariatric surgery within the previous 6 months * Use of pharmacological treatments that could affect weight loss, including GLP-1 receptor agonists or corticosteroids * Diabetes mellitus * Malignancy * Advanced renal or hepatic disease * Any medical condition contraindicating EMS application

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Obesity & overweight are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder Overweight Weight Loss

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Feray ÇAĞIRAN YILMAZ

    Kayapınar, Diyarbakır, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.